Jazz Pharmaceuticals (JAZZ) EBITDA Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 481.00 |
| Dec 31, 2025 | -481.00 |
| Sep 30, 2025 | -2,755.00 |
| Jun 30, 2025 | -10,087.00 |
| Mar 31, 2025 | 4,321.00 |
| Dec 31, 2024 | 700.00 |
| Sep 30, 2024 | -9.00 |
| Jun 30, 2024 | -1,877.00 |
| Mar 31, 2024 | -3,240.00 |
| Dec 31, 2023 | -2,673.00 |
| Sep 30, 2023 | -2,249.00 |
| Jun 30, 2023 | -1,414.00 |
| Mar 31, 2023 | -563.00 |
| Dec 31, 2022 | -5,945.00 |
| Sep 30, 2022 | -1,836.00 |
| Jun 30, 2022 | -3,268.00 |
| Mar 31, 2022 | -2,544.00 |
| Dec 31, 2021 | -3,622.00 |
| Sep 30, 2021 | -3,303.00 |
| Jun 30, 2021 | -5,353.00 |
| Mar 31, 2021 | -938.00 |
| Dec 31, 2020 | -522.00 |
| Sep 30, 2020 | -593.00 |
| Jun 30, 2020 | -1,071.00 |
| Mar 31, 2020 | -7,322.00 |
| Dec 31, 2019 | -2,906.00 |
| Sep 30, 2019 | 582.00 |
| Jun 30, 2019 | 1,274.00 |
| Mar 31, 2019 | 5,331.00 |
| Sep 30, 2018 | -310.00 |
| Jun 30, 2018 | -640.00 |
| Mar 31, 2018 | -1,500.00 |
| Dec 31, 2017 | -432.00 |
| Sep 30, 2017 | -1,052.00 |
| Jun 30, 2017 | 1,011.00 |
| Mar 31, 2017 | 135.00 |
| Dec 31, 2016 | -336.00 |
| Sep 30, 2016 | -1,026.00 |
| Jun 30, 2016 | -908.00 |
| Mar 31, 2016 | -837.00 |
| Dec 31, 2015 | 71.00 |
| Sep 30, 2015 | 1,888.00 |
| Jun 30, 2015 | 2,954.00 |